STOCK TITAN

Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Tandem Diabetes Care (NASDAQ: TNDM) will release its second quarter 2024 financial results on Thursday, August 1, 2024, after the market closes. The company will hold a conference call and webcast at 4:30 pm Eastern Time (1:30 pm Pacific Time) on the same day to discuss the financial and operating results. The live webcast will be available on Tandem Diabetes Care's Investor Center website. An archived version of the webcast will be accessible for 30 days post-event.

Positive
  • Announcement of financial results provides transparency and keeps investors informed.
  • Scheduled conference call allows direct communication with investors and analysts.
Negative
  • None.

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2024 results after the financial markets close on Thursday, August 1, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its second quarter 2024 financial and operating results.

A live webcast of the call will be available on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section. To access the call by phone, please use this link (https://register.vevent.com/register/BIc1efe0f41c4149d2ae27551b0212f1cf) and you will be provided with dial-in details, including a personal pin.

An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com.

Tandem Diabetes Care, the Tandem logo, Control-IQ, Tandem Mobi and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries.

Media Contact:

858-366-6900

media@tandemdiabetes.com



Investor Contact:

858-366-6900

IR@tandemdiabetes.com

Source: Tandem Diabetes Care, Inc.

FAQ

When will Tandem Diabetes Care release its second quarter 2024 financial results?

Tandem Diabetes Care will release its second quarter 2024 financial results on August 1, 2024, after the market closes.

What time is Tandem Diabetes Care's conference call for Q2 2024 results?

The conference call to discuss Q2 2024 results will be held at 4:30 pm Eastern Time (1:30 pm Pacific Time) on August 1, 2024.

Where can I access the webcast of Tandem Diabetes Care's Q2 2024 financial results?

The webcast will be available on Tandem Diabetes Care's Investor Center website under the 'Events & Presentations' section.

How long will the archive of Tandem Diabetes Care's Q2 2024 webcast be available?

The archived webcast will be available for 30 days following the event.

What is the stock symbol for Tandem Diabetes Care?

The stock symbol for Tandem Diabetes Care is TNDM.

Tandem Diabetes Care, Inc.

NASDAQ:TNDM

TNDM Rankings

TNDM Latest News

TNDM Stock Data

2.90B
65.47M
0.76%
114.45%
15.55%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
San Diego